Lilly Pulitzer’s treasured Sunshine Sale is back with splurge-worthy discounts and new styles perfect for the winter or ...

Lilly Pulitzer’s Sunshine Sale is here, and it’s brimming with vibrant dresses, blouses, and more fashion finds up to 78 percent off. Whether you’re hoping to refresh your wardrobe with ...

The 2025 Lilly Pulitzer Sunshine Sale has up to 70% off activewear, dresses, sweaters, accessories, home decor, and more. This rare event happens twice a year—shop now before your favorites sell ...

Telnaes, who won a Pulitzer Prize for Editorial Cartooning in 2001, has long been an advocate for free speech and editorial cartoons as a tool for civic debate. She serves on the advisory board ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.

Step into playful elegance with these bubble jelly sandals, combining fun, textured design with the perfect balance of comfort and style for sunny days.

Senior equity analysts at StockNews.com upgraded Eli Lilly (LLY, Financial) stock from 'hold' to 'buy' as its stock has shifted positively. Analysts say the upgrade is a sign of increased ...

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation.